(MPW) Medical Properties Trust - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US58463J3041

MPW: Hospitals, Healthcare, Real Estate, Facilities, Beds

Medical Properties Trust, Inc. (NYSE: MPW) stands as a prominent figure in the healthcare real estate sector, established in 2003. The companys ascent from its origins in Birmingham, Alabama, to becoming a global leader with 441 facilities and around 44,000 licensed beds as of September 2023 underscores its strategic prowess. Following the third quarter, the divestiture of four facilities adjusted their holdings to approximately 43,000 beds across nine countries and three continents.

MPWs business model is rooted in acquiring and leasing hospital facilities through net leases, ensuring a steady cash flow. This approach empowers hospital operators to monetize their real estate, channeling funds into critical areas like infrastructure, technology, and operational enhancements. Their role extends beyond mere real estate investment, positioning them as strategic partners in healthcare delivery.

Financially, MPW boasts a market capitalization of $2.97 billion, with a forward P/E of 6.67 and a price-to-book ratio of 0.53. These metrics highlight its attractive valuation. The companys focus on high-quality, income-generating assets underpins its investment appeal, offering a stable revenue stream through long-term leases, typically spanning 15 to 20 years.

Investors are drawn to MPWs resilience; healthcare infrastructure demand remains robust, shielded from economic fluctuations. The companys global diversification across the U.S., Europe, and Australia mitigates regional risks. Managements deep sector expertise further enhances their ability to navigate the complex healthcare landscape, ensuring alignment with operators needs and fostering mutually beneficial partnerships.

MPWs strategic initiatives, including selective acquisitions and portfolio optimization, reinforce their position as a leading healthcare REIT. Their commitment to sustainable growth and strong governance practices underscores their reliability as an investment avenue in the healthcare real estate sector.

Additional Sources for MPW Stock

MPW Stock Overview

Market Cap in USD 3,628m
Sector Real Estate
Industry REIT - Healthcare Facilities
GiC Sub-Industry Health Care REITs
IPO / Inception 2005-07-08

MPW Stock Ratings

Growth 5y -43.0%
Fundamental -30.7%
Dividend 36.2%
Rel. Strength 34.8
Analysts 2.67/5
Fair Price Momentum 6.23 USD
Fair Price DCF 1.92 USD

MPW Dividends

Dividend Yield 12m 10.32%
Yield on Cost 5y 5.03%
Annual Growth 5y -15.69%
Payout Consistency 93.8%

MPW Growth Ratios

Growth Correlation 3m 96.4%
Growth Correlation 12m 24.3%
Growth Correlation 5y -80.8%
CAGR 5y -11.25%
CAGR/Max DD 5y -0.13
Sharpe Ratio 12m -0.81
Alpha 42.75
Beta 1.365
Volatility 41.13%
Current Volume 5013.8k
Average Volume 20d 9112.6k
What is the price of MPW stocks?
As of April 03, 2025, the stock is trading at USD 5.91 with a total of 5,013,784 shares traded.
Over the past week, the price has changed by -3.59%, over one month by +3.63%, over three months by +48.99% and over the past year by +52.80%.
Is Medical Properties Trust a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Medical Properties Trust (NYSE:MPW) is currently (April 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -30.74 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MPW as of April 2025 is 6.23. This means that MPW is currently overvalued and has a potential downside of 5.41%.
Is MPW a buy, sell or hold?
Medical Properties Trust has received a consensus analysts rating of 2.67. Therefor, it is recommend to hold MPW.
  • Strong Buy: 0
  • Buy: 1
  • Hold: 7
  • Sell: 3
  • Strong Sell: 1
What are the forecast for MPW stock price target?
According to ValueRays Forecast Model, MPW Medical Properties Trust will be worth about 6.7 in April 2026. The stock is currently trading at 5.91. This means that the stock has a potential upside of +13.87%.
Issuer Forecast Upside
Wallstreet Target Price 5.5 -6.9%
Analysts Target Price 4.6 -22.8%
ValueRay Target Price 6.7 13.9%